3-PHOSPHINIC ACID AND 3-PHOSPHONIC ACID STEROIDS AS INHIBITORS OF STEROID 5-ALPHA-REDUCTASE - SPECIES COMPARISON AND MECHANISTIC STUDIES

被引:24
作者
LEVY, MA
METCALF, BW
BRANDT, M
ERB, JM
OH, HJ
HEASLIP, JI
YEN, HK
ROZAMUS, LW
HOLT, DA
机构
[1] Department of Medicinal Chemistry, SmithKline Beecham Pharmaceuticals, King of Prussia
关键词
D O I
10.1016/0045-2068(91)90050-Y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
3-Phosphinic acid and 3-phosphonic acid steroids are presented as a new class of steroid 5α-reductase (SR) inhibitors. Representative compounds have been studied as inhibitors of prostatic SR from human, rat, and cynomolgus monkey (Macaca fascicularis). The most potent of the phosphinic acid inhibitors of the human enzyme activity demonstrated nanomolar inhibition constants, while the affinities of the phosphonic acids were diminished. Comparison of compound potency revealed interspecies variability with the best correlation on Ki Km for the two primate SRs. Results from dead-end and multiple inhibition analyses with 17β-(N,N-diisopropylcarbamoyl)androsta-3,5-diene-3-phosphinic acid (2a) and 17β-(N,N-diisopropylcarbamoyl)androsta-3,5-diene-3-phosphinic acid (3a) were consistent with the preferential binding of these compounds to an enzyme-NADP+ complex. The pH profiles of solubilized rat liver SR inhibition by 2a and 3a indicated preferential binding of the phosphinic and phosphonic acids as the anion and the monoanion, respectively. © 1991.
引用
收藏
页码:245 / 260
页数:16
相关论文
共 50 条
[31]   PARTIAL-PURIFICATION OF HUMAN PROSTATIC 5-ALPHA-REDUCTASE (3-OXO-5-ALPHA-STEROID-NADP+ 4-ENE-OXIDO-REDUCTASE, EC 1.3.1.22) IN A STABLE AND ACTIVE FORM [J].
SARGENT, NSE ;
HABIB, FK .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1991, 38 (01) :73-77
[32]   DIFFERENTIAL REGULATION OF STEADY-STATE 4-ENE STEROID 5-ALPHA-REDUCTASE MESSENGER-RIBONUCLEIC-ACID LEVELS ALONG THE RAT EPIDIDYMIS [J].
VIGER, RS ;
ROBAIRE, B .
ENDOCRINOLOGY, 1991, 128 (05) :2407-2414
[33]   3D-QSAR CoMFA and CoMSIA studies for design of potent human steroid 5α-reductase inhibitors [J].
Rajnish Kumar ;
Manoj Kumar .
Medicinal Chemistry Research, 2013, 22 :105-114
[34]   3D-QSAR CoMFA and CoMSIA studies for design of potent human steroid 5α-reductase inhibitors [J].
Kumar, Rajnish ;
Kumar, Manoj .
MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (01) :105-114
[35]   ACID CATALYSED REACTIONS OF 5ALPHA-HYDROXY-STEROIDS .3. WESTPHALEN REARRANGEMENT [J].
BLUNT, JW ;
FISCHER, A ;
HARTSHOR.MP ;
JONES, FW ;
KIRK, DN ;
YOONG, SW .
TETRAHEDRON, 1965, 21 (06) :1567-&
[36]   HYDROXYLATION OF 5-ALPHA-ANDROSTANE-3-BETA, 17-BETA-DIOL BY RAT PROSTATE MICROSOMES - POTENT INHIBITION BY IMIDAZOLE-TYPE ANTIMYCOTIC DRUGS AND LACK OF INHIBITION BY STEROID 5-ALPHA-REDUCTASE INHIBITORS [J].
GEMZIK, B ;
PARKINSON, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 296 (02) :366-373
[37]   (E)-4-(2-[[3-(INDOL-5-YL)-L-OXO-2-BUTENYL]AMINO]PHENOXY)BUTYRIC ACID-DERIVATIVES - A NEW CLASS OF STEROID 5-ALPHA-REDUCTASE INHIBITORS IN THE RAT PROSTATE .1. [J].
KUMAZAWA, T ;
TAKAMI, H ;
KISHIBAYASHI, N ;
ISHII, A ;
NAGAHARA, Y ;
HIRAYAMA, N ;
OBASE, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (15) :2887-2892
[38]   Abnormally low ratio of cholic acid to chenodeoxycholic acid due to a deficiency of 3-oxo-Δ4-steroid 5β-reductase [J].
Kimura, A ;
Nittono, H ;
Takei, H ;
Kurosawa, T .
PEDIATRICS INTERNATIONAL, 2000, 42 (05) :594-594
[39]   Design of potent human steroid 5α-reductase inhibitors: 3D-QSAR CoMFA, CoMSIA and docking studies [J].
Kumar, Rajnish ;
Malla, Priyanka ;
Verma, Abhilasha ;
Kumar, Manoj .
MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (10) :4568-4580
[40]   Design of potent human steroid 5α-reductase inhibitors: 3D-QSAR CoMFA, CoMSIA and docking studies [J].
Rajnish Kumar ;
Priyanka Malla ;
Abhilasha Verma ;
Manoj Kumar .
Medicinal Chemistry Research, 2013, 22 :4568-4580